CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles' Heel?
Details
Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY 4.0
UNIL restricted access
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_FD79D8B405D7
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles' Heel?
Journal
Frontiers in immunology
ISSN
1664-3224 (Electronic)
ISSN-L
1664-3224
Publication state
Published
Issued date
2021
Peer-reviewed
Oui
Volume
12
Pages
766220
Language
english
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Publication Status: epublish
Keywords
Animals, CD28 Antigens, Dimerization, Humans, Immunotherapy, Adoptive/adverse effects, Receptors, Chimeric Antigen, CD19 CAR T-cell, CD28, chimeric antigen receptor, cytokine release syndrome, heterodimerization, immune effector cell-associated neurotoxicity syndrome, neurotoxicity, transmembrane domain
Pubmed
Web of science
Open Access
Yes
Create date
11/12/2021 12:11
Last modification date
12/08/2022 5:40